Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten J Postma

Showing results (21-30 of 485) with videos related to

Pageof 49
Sort By:
Vaccine|December 19, 2012
Response on "RE: Cost-effectiveness of pertussis booster vaccination in the Netherlands"Mark H Rozenbaum, Maarten J Postma
Expert Review of Vaccines|August 23, 2014
Expanding access to non-traditional vaccines: a perspective from IndonesiaAuliya A Suwantika, Maarten J Postma
Nederlands Tijdschrift Voor Geneeskunde|February 20, 2020
[Continue to use the bivalent HPV vaccine; bivalent vaccine more effective than expected]Maarten J Postma, Jan C Wilschut
The Lancet. Infectious Diseases|July 22, 2022
Universal financing and coverage of vaccinesLouis W Niessen, Maarten J Postma
Journal of Market Access & Health Policy|April 29, 2016
The societal role of lifelong vaccinationMaarten J Postma, Stuart Carroll, Alexandra Brandão
European Journal of Preventive Cardiology|September 19, 2012
A systematic review on the application of cardiovascular risk prediction models in pharmacoeconomics, with a focus on primary preventionJelena Stevanovic, Maarten J Postma, Petros Pechlivanoglou
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 9, 2010
Quantification of the potential impact of cost-effectiveness thresholds on dutch drug expenditures using retrospective analysisCornelis Boersma, Adriaan Broere, Maarten J Postma
Expert Opinion on Pharmacotherapy|October 22, 2002
Cost-effectiveness of widespread screening for Chlamydia trachomatisMaarten J Postma, Robert Welte, Servaas A Morré
Journal of Medical Economics|May 20, 2009
Cost effectiveness of oseltamivir treatment of influenza: a critique of published methods and outcomesMaarten J Postma, Paul Beardsworth, Jan C Wilschut
Value in Health Regional Issues|April 5, 2021
Persistent Socioeconomic Inequalities in Measles Vaccine Uptake in Ethiopia in the Period 2005 to 2016Abrham Wondimu, Marinus van Hulst, Maarten J Postma
Pageof 49

Showing results (21-30 of 485) with videos related to

Sort By:
Pageof 49
Vaccine|December 19, 2012
Response on "RE: Cost-effectiveness of pertussis booster vaccination in the Netherlands"Mark H Rozenbaum, Maarten J Postma
Expert Review of Vaccines|August 23, 2014
Expanding access to non-traditional vaccines: a perspective from IndonesiaAuliya A Suwantika, Maarten J Postma
Nederlands Tijdschrift Voor Geneeskunde|February 20, 2020
[Continue to use the bivalent HPV vaccine; bivalent vaccine more effective than expected]Maarten J Postma, Jan C Wilschut
The Lancet. Infectious Diseases|July 22, 2022
Universal financing and coverage of vaccinesLouis W Niessen, Maarten J Postma
Journal of Market Access & Health Policy|April 29, 2016
The societal role of lifelong vaccinationMaarten J Postma, Stuart Carroll, Alexandra Brandão
European Journal of Preventive Cardiology|September 19, 2012
A systematic review on the application of cardiovascular risk prediction models in pharmacoeconomics, with a focus on primary preventionJelena Stevanovic, Maarten J Postma, Petros Pechlivanoglou
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 9, 2010
Quantification of the potential impact of cost-effectiveness thresholds on dutch drug expenditures using retrospective analysisCornelis Boersma, Adriaan Broere, Maarten J Postma
Expert Opinion on Pharmacotherapy|October 22, 2002
Cost-effectiveness of widespread screening for Chlamydia trachomatisMaarten J Postma, Robert Welte, Servaas A Morré
Journal of Medical Economics|May 20, 2009
Cost effectiveness of oseltamivir treatment of influenza: a critique of published methods and outcomesMaarten J Postma, Paul Beardsworth, Jan C Wilschut
Value in Health Regional Issues|April 5, 2021
Persistent Socioeconomic Inequalities in Measles Vaccine Uptake in Ethiopia in the Period 2005 to 2016Abrham Wondimu, Marinus van Hulst, Maarten J Postma
Pageof 49